Fritextsökning
Innehållstyper
-
Prenatal testing breakthrough
For the first time specific gene expression information from fetal cells isolated from maternal blood samples is available.
-
Athera signs production partnership
The companys novel cardiovascular product will be manufactured in Germany.
-
Första patienterna har testat kräm för hårväxtstimulering
Nu har Follicums fas II-studie med FOL-005-kräm startat på riktigt. De första manliga patienterna med håravfall har nu behandlats.
-
Valnevas Sverige-chef: ”Vi hoppas på en lösning med EU-kommissionen”
EMA:s vetenskapliga kommitté fortsätter sin rolling review för Valnevas covidvaccin. "Under längre tid har vi haft interaktioner med EMA relaterade till vår rol...
-
Hey Kurt Berndt...
... who is starting up a research center for youths in Saltsjöbaden.
-
Orion cuts 205 jobs
The Finnish company Orion has completed its statutory negotiations. By this, personnel will be reduced by about 205 in Finland.
-
Danisco first with green emulsifier
A new sustainable emulsifier from Danisco meets the increasing consumer demand for ethically correct consumer goods.
-
Parnevik firm in Swiss osteoporosis deal
The golf legend Jesper Parnevik's drug delivery firm EffRx has signed a license agreement with Nycomed for a new drug against osteoporosis.
-
Double the channels for half the work
The 16-well pipettes from Capp cause less strain for the user when setting up a 384-well plate.
-
Medicult disclaims Swedish offer
The Norwegian company Medicult's Board is highly sceptical to the yesterday announced Vitrolife offer.
-
Meda gets access to Asia
The biotech giant Meda has recently acquires world-wide rights to the cancer breakthrough pain drug Onsolis.
-
Astra Zeneca lovar leverans av 2 miljarder vaccindoser mot corona
Totalt har läkemedelsföretaget ingått avtal med flera producenter och lovar nu leverans om totalt 2 miljoner vaccindoser mot det nya coronaviruset.
-
Missnöjd med din julklappsslips? Här är våra läsetips
-
Orexo opens doors eastwards
The drug delivery company has signed a deal for selling a cancer pain treatment in China. "An ideal partner for us" says Torbjörn Bjerke, CEO of Orexo.
-
Many rotor options for refrigerated microcentrifuge
The new 5430 R from Eppendorf is a refrigerated microcentrifuge with several different rotors.
-
Will the industry follow the economic revival?
Welcome to the eleventh Biotech Forum + Scanlab Fair!
-
Multiple rotor options in refrigerated microcentrifuge
The new 5430 R from Eppendorf is a refrigerated microcentrifuge with several different rotors.
-
Acadia drug awarded
Acadia Pharmaceutical has got an award for a new treatment against Parkinson's disease.
-
Anything is measurable
At the seminar "Du är vad jag mäter - hjärnans kemi i ett provrör", Jonas Bergquist, professor of analytical chemistry and neurochemistry, will dig deep into th...
-
GSK bäst på läkemedel i utvecklingsländer
Rankas etta på Access to medicines index för tredje gången i rad.
-
Norwegian cancer therapy leaves phase II
New clinical results from Algeta highlights the potential of Alpharadin to treat bone metastases in major cancer indications.
-
Bio-Linux goes global
Recently the NEBC Bio-Linux Version 5.0 was released, a one-stop shop for bioinformatics tools in a Linux context.
-
EU says yes to Roche drug
EU approves a first in class therapy for treatment of patients with moderate to severe form of rheumatoid arthritis.
-
Sectra levererar till London
Tecknar tioårigt avtal med det brittiska sjukhuset Kingston Hospital.